Vivos (RDGL) Cash & Equivalents Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 156.03% |
| 10 | Vivos | - | - | -3,105.00 | -29.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29.56% |
| Sep 30, 2025 | 80.77% |
| Jun 30, 2025 | 54.29% |
| Mar 31, 2025 | 138.18% |
| Dec 31, 2024 | 38.95% |
| Sep 30, 2024 | -20.74% |
| Jun 30, 2024 | -1.39% |
| Mar 31, 2024 | -2.95% |
| Dec 31, 2023 | -6.67% |
| Sep 30, 2023 | -22.68% |
| Jun 30, 2023 | 66.44% |
| Mar 31, 2023 | 15.60% |
| Dec 31, 2022 | 6.22% |
| Sep 30, 2022 | 0.06% |
| Jun 30, 2022 | -51.46% |
| Mar 31, 2022 | -51.36% |
| Dec 31, 2021 | 77.73% |
| Sep 30, 2021 | 13,202.47% |
| Jun 30, 2021 | 769.85% |
| Dec 31, 2020 | 4,334.05% |
| Sep 30, 2020 | -90.58% |
| Jun 30, 2020 | 2,827.02% |
| Dec 31, 2019 | 270.97% |
| Mar 31, 2019 | 261,081.25% |
| Dec 31, 2018 | -33.94% |
| Mar 31, 2018 | -99.93% |
| Dec 31, 2017 | -70.18% |
| Sep 30, 2017 | 147,300.00% |
| Jun 30, 2017 | 201,784.70% |
| Mar 31, 2017 | -90.44% |
| Dec 31, 2016 | -84.42% |
| Sep 30, 2016 | -99.80% |
| Jun 30, 2016 | -99.30% |
| Mar 31, 2016 | 9,877.34% |
| Dec 31, 2015 | 88,093.10% |
| Sep 30, 2015 | 1,308.76% |
| Jun 30, 2015 | -79.06% |
| Mar 31, 2015 | -97.29% |
| Sep 30, 2014 | -98.00% |
| Jun 30, 2014 | 1,692.76% |
| Mar 31, 2014 | 35.72% |
| Sep 30, 2013 | -44.66% |
| Jun 30, 2013 | -49.53% |
| Dec 31, 2012 | -87.80% |
| Sep 30, 2012 | 154.03% |
| Jun 30, 2012 | 169.74% |
| Dec 31, 2011 | -91.08% |
| Sep 30, 2011 | -96.65% |
| Jun 30, 2011 | -90.00% |